DHS 145.07 DHS 145.07 Special disease control measures.

DHS 145.07(1) (1) Schools and day care centers. Any teacher, principal, director or nurse serving a school or day care center may send home, for the purpose of diagnosis and treatment, any pupil suspected of having a communicable disease or of having any other disease or condition having the potential to affect the health of other students and staff including but not limited to pediculosis and scabies. The teacher, principal, director or nurse authorizing the action shall ensure that the parent, guardian or other person legally responsible for the child or other adult with whom the child resides and the nurse serving the child’s school or day care center are immediately informed of the action. A teacher who sends a pupil home shall also notify the principal or director of the action.

DHS 145.07(2) (2) Personal care. Home health agency personnel providing personal care in the home and persons providing personal care in health care facilities, day care centers and other comparable facilities shall refrain from providing care while they are able to transmit a communicable disease through the provision of that care, in accord with the methods of communicable disease control contained in official guidance of the Centers for Disease Control and Prevention, unless specified otherwise by the state epidemiologist.

DHS 145.07 Note Note: The official guidance of the Centers for Disease Control and Prevention entitled, “Guideline for Infection Control in Health Care Personnel, 1998,” is on file in the Department’s Division of Public Health and the Legislative Reference Bureau, and may be found in the American Journal of Infection Control, vol. 26, 1998, pp. 289-354.

DHS 145.07(3) (3) Food handlers. Food handlers shall refrain from handling food while they have a disease in a form that is communicable by food handling, in accord with the methods of communicable disease control contained in the official report of the American Public Health Association, unless specified otherwise by the state epidemiologist.

DHS 145.07 Note Note: The official report of the American Public Health Association entitled Control of Communicable Disease Manual, 20th edition (2015), edited by David L. Heymann, is on file in the Department’s Division of Public Health and the Legislative Reference Bureau, and is available for purchase from the American Public Health Association, Publication Sales, PO Box 933019, Atlanta, GA 31193-3019.

DHS 145.07(4) (4) Prevention of ophthalmia neonatorum. The attending physician or midwife shall ensure placement of 2 drops of a one percent solution of silver nitrate, or a 1-2 centimeter ribbon of an ophthalmic ointment containing 0.5% erythromycin or one percent tetracycline, in each eye of a newborn child as soon as possible after delivery but not later than one hour after delivery. No more than one newborn child may be treated from an individual container.

DHS 145.07 History History: Cr. Register, April, 1984, No. 340, eff. 5-1-84; r. and recr. (4), Register, November, 1984, No. 347, eff. 12-1-84; am. (1) to (3), Register, February, 1989, No. 398, eff. 3-1-89; renum. from HFS 145.06 and am., Register, March, 2000, No. 531, eff. 4-1-00; CR 17-014: am. (2), (3), Register June 2018 No. 750 eff. 7-1-18; correction in (3) made under s. 35.17, Stats., Register June 2018 No. 750.

subch. II of ch. DHS 145 Subchapter II — Tuberculosis

DHS 145.08 DHS 145.08 Definitions. In this subchapter:

DHS 145.08(1) (1) “Case management” means the creation and implementation of an individualized treatment plan for a person with tuberculosis infection or disease that ensures that the person receives appropriate treatment and support services in a timely, effective, and coordinated manner.

DHS 145.08(2) (2) “Confinement” means the restriction of a person with tuberculosis to a specified place in order to prevent the transmission of the disease to others, to prevent the development of drug-resistant organisms or to ensure that the person receives a complete course of treatment.

DHS 145.08(3) (3) “Contact” means a person who shares air with a person who has infectious tuberculosis.

DHS 145.08(4) (4) “Contact investigation” means the process of identifying, examining, evaluating and treating a person at risk of infection with Mycobacterium tuberculosis due to recent exposure to infectious tuberculosis or suspected tuberculosis.

DHS 145.08(5) (5) “Directly observed therapy” means the ingestion of prescribed anti-tuberculosis medication that is observed by a health care worker or other responsible person acting under the authority of the local health department.

DHS 145.08(6) (6) “Infectious tuberculosis” means tuberculosis disease of the respiratory tract capable of producing infection or disease in others, as demonstrated by the presence of acid–fast bacilli in the sputum or bronchial secretions, or by radiographic and clinical findings.

DHS 145.08(7) (7) “Isolate” means a population of Mycobacterium tuberculosis bacteria that has been obtained in pure culture medium.

DHS 145.08(8) (8) “Isolation” means the separation of persons with infectious tuberculosis from other persons, in a place and under conditions that will prevent transmission of the infection.

DHS 145.08(9) (9) “Licensed prescriber” means an advanced practice nurse prescriber, a physician assistant, or other person licensed to prescribe medication under Wisconsin law.

DHS 145.08(10) (10) “Public health dispensary” means a program of a local health department or group of local health departments to prevent and control tuberculosis disease and infection by the identification, medical evaluation, treatment and management of persons at risk for tuberculosis infection or disease.

DHS 145.08(11) (11) “Repository” means a central location at the Wisconsin State Laboratory of Hygiene for receipt and storage of patient isolates of Mycobacterium tuberculosis.

DHS 145.08(12) (12) “Sputum conversion” means the conversion of serial sputum cultures for Mycobacterium tuberculosis from positive to negative, in response to effective treatment.

DHS 145.08(13) (13) “Suspected tuberculosis” means an illness marked by symptoms, signs, or laboratory tests that may be indicative of infectious tuberculosis such as prolonged cough, prolonged fever, hemoptysis, compatible radiographic findings or other appropriate medical imaging findings.

DHS 145.08(14) (14) “Tuberculosis disease” means an illness determined by clinical or laboratory criteria or both to be caused by Mycobacterium tuberculosis.

DHS 145.08(15) (15) “Tuberculosis infection” means an infection with Mycobacterium tuberculosis in a person who has no symptoms of tuberculosis disease and is not infectious.

DHS 145.08 History History: Cr. Register, April, 1984, No. 340, eff. 5-1-84; r. and recr. Register, March, 2000, No. 531, eff. 4-1-00; CR 01-105: r. and recr. Register March 2002 No. 555, eff. 4-1-02.

DHS 145.09 DHS 145.09 Laboratory procedures.

DHS 145.09(1) (1) Any laboratory that receives a specimen for tuberculosis testing shall report all positive results as specified in s. DHS 145.04, including those obtained by an out-of-state laboratory, to the local health officer and to the department. The laboratory shall also submit an isolate from a patient with a positive culture to the state repository.

DHS 145.09 Note Note: Isolates for the state repository should be sent to: Mycobacteriology Laboratory, Wisconsin State Laboratory of Hygiene, 2601 Agriculture Dr., Room 254, Madison, WI 53718.